About Gemeinschaftskrankenhaus Havelhöhe
Clinical Trials at Gemeinschaftskrankenhaus Havelhöhe
During the past decade, Gemeinschaftskrankenhaus Havelhöhe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gemeinschaftskrankenhaus Havelhöhe" #1 sponsor was "Aktion Bronchialkarzinom e.V." with 1 trials, followed by "Boston Scientific Corporation" with 1 trials
sponsored, "Profil Institut für Stoffwechselforschung GmbH" with 1 trials sponsored, "Terumo Europe N.V." with 1 trials sponsored and "Uptake Medical Technology, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftskrankenhaus Havelhöhe"
#1 collaborator was "Pfizer" with 1 trials as a collaborator, "PneumRx, Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Gemeinschaftskrankenhaus Havelhöhe
According to Clinical.Site data, the most researched conditions in "Gemeinschaftskrankenhaus Havelhöhe" are
"Carcinoma, Non-Small-Cell Lung" (1 trials), "Coronary Artery Disease" (1 trials), "Emphysema" (1 trials), "Emphysema or COPD" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Gemeinschaftskrankenhaus Havelhöhe" in a lesser frequency.
Clinical Trials Intervention Types at Gemeinschaftskrankenhaus Havelhöhe
Most popular intervention types in "Gemeinschaftskrankenhaus Havelhöhe" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atorvastatin" (1 trials), "Bevacizumab" (1 trials), "Bronchoscopic Thermal Vapor Ablation" (1 trials), "Cisplatin" (1 trials) and "Erlotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gemeinschaftskrankenhaus Havelhöhe
The vast majority of trials in "Gemeinschaftskrankenhaus Havelhöhe" are
5 trials for "All" genders.
Clinical Trials Status at Gemeinschaftskrankenhaus Havelhöhe
Currently, there are NaN active trials in "Gemeinschaftskrankenhaus Havelhöhe".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Gemeinschaftskrankenhaus Havelhöhe,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Gemeinschaftskrankenhaus Havelhöhe, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".